Le Lézard
Classified in: Science and technology
Subject: Event

AtScale Releases Keynote Lineup, Full Agenda and Registration for 2024 Semantic Layer Summit


AtScale, the leading provider of semantic layer solutions for analytics and generative AI, today announced the keynote line up for its Semantic Layer Summit. On Wednesday, April 24, 2024, thousands of data leaders, engineers, architects and analysts will join virtually to learn about the most recent innovations in data, analytics, Generative AI, and business intelligence (BI) as it relates to semantic layers in the enterprise.

This event marks the third-annual Summit, drawing over 8,000 registrants and featuring speakers from across the industry. Attendees can expect to hear from top industry experts, researchers, and practitioners as they share best practices and personal experiences. Highlights include sessions from data leaders at top enterprise companies like Saks, Netflix, T-Mobile, John Deere, Cardinal Health, and more.

Semantic Layer Summit's featured keynote delivered by AtScale's co-founder and CTO David P. Mariani and AtScale's Head of Product, Elif Tutuk, will explore important new innovations in semantic layer platforms as it relates to the concepts of composable semantic modeling, decentralized data product innovation, and ecosystem integration. Attendees will also hear from a broad lineup of data leaders, global thought leaders, and practitioners including:

This year, the single-day virtual event will run from 10:00 am ? 3:30 pm EST and cover a range of topics, technical sessions, and virtual networking opportunities including the following agenda highlights:

For more information, please see the full preliminary agenda here. Register here.

New speakers and participating partners are being added daily, with confirmed participation from leading data and analytics companies like Cube, Intersystems, Google Cloud, Snowflake and Snowplow.

For more information about how you can be a part of one of this year's biggest one-day gatherings of data experts please contact us at: [email protected].

About AtScale
AtScale enables smarter decision-making by accelerating the flow of data-driven insights. The company's semantic layer platform simplifies, accelerates, and extends business intelligence and data science capabilities for enterprise customers across all industries. With AtScale, customers are empowered to democratize data, implement self-service BI and build a more agile analytics infrastructure for better, more impactful decision-making. For more information, please visit www.atscale.com and follow us on LinkedIn, Twitter or Facebook.


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: